ÂÜÀòÉç

Introduction

Ion Channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting ion channels have been discovered for diseases such as hypertension, epilepsy and chronic neuropathic pain, but few were rational designed until recently. Advances aiding design of new therapeutics include: refinement of high-throughput electrophysiology platforms; the genetic association of ion channel targets with human disease providing validated targets); the successful determination of the 3-dimensional structures of several ion channels; and the demonstration of antibodies capable of specifically modulating channel subtypes. The conference will be organised around series of plenary Lectures and seminars delivered by international leaders in ion channels science and drug discovery from academia and industry. In addition there will be a poster session, an exhibition and opportunities for informal networking.

Deadlines

• Dec 10 2014
  Oral abstracts deadline

  
• Dec 30 2015
  Early bird registration deadline

  
• Feb 07 2016
  Standard registration deadline

  
• Feb 14 2016
  Poster abstract deadline

  
• Feb 19 2016
  Bursary application deadline

  

Useful links

Downloads

• Registration form
• Final announcement
• Venue directions

Speakers

• Giuseppe Alvaro Autifony, United Kingdom
• Kaustav Biswas Amgen, United States
• Patrick Stoy GlaxoSmithKline, United Kingdom
• Bonnie Wallace Birkbeck College, United Kingdom
• Alan Brown Pfizer Worldwide Medicinal Chemistry, United Kingdom
• Yifan Cheng University of California San Francisco, United States
• Ben Corry Australian National University, Australia
• Mustafa Djamgoz Imperial College London, United Kingdom
• Stephen Hess Evotec, Germany
• David Madge WuXi AppTec, United Kingdom
• Gareth Young Pfizer Neuroscience and Pain
  , Ukraine
• Simon Tate Convergence, United Kingdom

---

Sponsorship & supporting organisations

---

Sponsors

Charles River

MedImmune

Convergence

Venue

Wellcome Genome Campus Conference Centre

Wellcome Genome Campus Conference Centre, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Useful links

Committee

• Brian Cox University of Sussex, United Kingdom
• Karl Gibson Sandexis, United Kingdom
• Nigel Swain Pfizer, United Kingdom
• David Witty (chairman) Convergence, United Kingdom

---

Organised by

RSC-BMCS

SCI-FCG

Contact information

Mrs Maggi Churchouse
Maggi Churchouse Events
3 East Barn
Market Weston Road
Thelnetham
Diss
IP22 1JJ
UK
01359 221004
Contact us by email

---